Auxly Cannabis Group Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CBWTF research report →
Price Chart
About the company
Auxly Cannabis Group Inc. operates as a Canadian consumer packaged goods firm within the cannabis sector. The company's core activities involve the development, manufacturing, and distribution of cannabis-based products for both wellness and recreational markets.
- CEO
- Hugo Alves
- IPO
- 2017
- Employees
- 446
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on CBWTF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $190.46M
- P/E
- 9.43
- Fwd P/E
- 191.17
- PEG
- 0.94
- P/S
- 1.92
- P/B
- 1.73
- EV/EBITDA
- 9.54
- Div Yield
- 0.00%
- Gross Margin
- 37.91%
- Op Margin
- 4.52%
- Net Margin
- 19.69%
- ROE
- 18.12%
- ROIC
- 3.13%
Latest fiscal year · YoY change
- Revenue
- $151.36M+23.7%
- Gross Profit
- $24.62M-58.9%
- Op Income
- $-24,412,088
- Net Income
- $41.82M+355.8%
- EPS
- $0.44+330.9%
- OCF Growth
- +54.2%
- FCF Growth
- +66.6%
- 52W High
- $2.20
- 52W Low
- $0.13
- 50D MA
- $1.71
- 200D MA
- $1.49
- Beta
- 1.20
- RSI (14)
- 60
- Avg Volume
- 47.76K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Auxly posted record Q2 results with strong revenue, EBITDA, and cash flow growth, while keeping its 2026 outlook unchanged and leaning on organic growth and share buybacks.· August 13, 2026
- Net revenue hit a quarterly record of $45.8 million, up 18% year over year.
- Adjusted EBITDA was a record $14.3 million, up 24% year over year, with a 31% margin for the fifth straight quarter.
- Gross margin on finished cannabis inventory sold rose to 55% from 52% in Q2 25, supported by higher yields, manufacturing improvements, and procurement savings.
- Cash flow from operations before working capital changes reached $13.4 million, up 31% year over year and equal to 94% conversion from adjusted EBITDA.
- Management kept 2026 guidance unchanged and plans additional Leamington expansion, including $10 million to $12 million previously guided for 2026, funded from cash from operations.
Auxly reported record Q2 26 net revenue of $45.8 million, up 18% year over year. Adjusted EBITDA was $14.3 million, up 24% year over year, with a 31% EBITDA margin. Gross margin on finished cannabis inventory sold was 55%, versus 52% in Q2 25. Cash flow from operations before working capital changes was $13.4 million, up 31% year over year and representing 94% conversion from adjusted EBITDA. Net income was $7.7 million, essentially flat versus $8.3 million in Q2 25. Looking ahead, management said its 2026 outlook is unchanged, expects net revenue growth above market rates, and reiterated a longer-term capital program of about $30 million over three years to increase yield at Auxly Leamington by about 30% over 2025 levels, including the previously guided $10 million to $12 million for 2026.
Hugo Alves framed the quarter as evidence that Auxly’s operating model is scaling, citing record revenue, EBITDA, and cash flow. He emphasized that strong demand for core brands, especially Back Forty, is driving growth, and said the company’s margin improvement is structural rather than temporary. He also signaled confidence in the long-term plan, including Leamington expansion, innovation, and continued share repurchases, while saying Auxly will stay focused on “winning at home” in Canada before pushing harder internationally.
Travis Wong said the 31% EBITDA margin is sustainable because it is being supported by three drivers: revenue growth above the market, structural gross margin improvement, and disciplined SG&A growth. He pointed to higher cultivation yields, better manufacturing at Leamington and Charlottetown, and procurement savings, including lower vape API costs. On profitability, he said net income was $7.7 million, but underlying net income would have improved meaningfully after excluding noncash fair value adjustments; he said underlying net income would have improved by $2.2 million year over year and by $8 million year to date. Management also said working capital should remain similar to last year with modest increases to support growth, and that improved cash conversion should benefit from lower interest expense.
Analysts focused on whether the 30% yield improvement at Leamington is realistic, with management explaining it will come from additional post-harvest capabilities, a new grow zone, and related infrastructure, and that yield gains should arrive throughout the three-year buildout through 2028. Questions also centered on whether the 31% EBITDA margin can last; management said it is supported by structural gross margin gains and controlled SG&A, though they acknowledged they will keep investing in sales and marketing as the business grows. On international markets, management said the opportunity is real but still too early and too dynamic to prioritize over Canada, so the company is focused on domestic execution while building relationships for the future. On capital allocation, Hugo Alves said Auxly will keep evaluating its NCIB alongside organic growth and other opportunities, and that at current prices the company views buybacks as attractive because it believes the stock does not reflect intrinsic value.
The call showed sustained operating momentum: record revenue, EBITDA, cash flow, and a 31% margin for the fifth straight quarter. Management sounded confident that growth and margins are being driven by structural improvements, strong consumer demand, and successful innovation across core brands like Back Forty and Liquid Imagination.
The main execution risk is that the company is committing to a meaningful multi-year Leamington expansion, with yield gains spreading over time rather than showing up all at once. Management also acknowledged international markets are still early and volatile, and that SG&A will rise as it invests in sales and marketing, which could pressure margins if revenue growth slows.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 77.5%
- Shares Outstanding
- 102.40M
- Float Shares
- 79.33M
Our CBWTF coverage
Recent articles, reports, and earnings notes.
No research on CBWTF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CBWTF report →Auxly Reports Second Quarter 2026 Results
prnewswire.com · Aug 13
Auxly to Report Second Quarter 2026 Financial Results on August 13, 2026
prnewswire.com · Jul 30
Auxly Announces Commencement of Trading Following 14:1 Share Consolidation
prnewswire.com · Jul 28
Auxly Announces 14:1 Share Consolidation
prnewswire.com · Jul 22
Auxly Announces Results of Annual General and Special Meeting of Shareholders
gurufocus.com · Jul 2
Auxly Announces Results of Annual General and Special Meeting of Shareholders
prnewswire.com · Jul 2
Red White & Bloom Brands' Subsidiary, Emblem Cannabis Corporation, Assumes Debtor-In-Possession Financing for Ayurcann Following Assignment From Auxly Cannabis Group
globenewswire.com · Jun 3
Auxly Cannabis Group Inc. (XLY:CA) Q1 2026 Earnings Call Transcript
seekingalpha.com · May 14
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.